158 related articles for article (PubMed ID: 35409322)
1. Forchlorfenuron and Novel Analogs Cause Cytotoxic Effects in Untreated and Cisplatin-Resistant Malignant Mesothelioma-Derived Cells.
Henzi T; Diep KL; Oberson A; Salicio V; Bochet CG; Schwaller B
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409322
[TBL] [Abstract][Full Text] [Related]
2. A Septin Cytoskeleton-Targeting Small Molecule, Forchlorfenuron, Inhibits Epithelial Migration via Septin-Independent Perturbation of Cellular Signaling.
Sun L; Cao X; Lechuga S; Feygin A; Naydenov NG; Ivanov AI
Cells; 2019 Dec; 9(1):. PubMed ID: 31905721
[TBL] [Abstract][Full Text] [Related]
3. The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells
Blum W; Henzi T; Pecze L; Diep KL; Bochet CG; Schwaller B
Oncotarget; 2019 Dec; 10(65):6944-6956. PubMed ID: 31857849
[TBL] [Abstract][Full Text] [Related]
4. Off-target effects of the septin drug forchlorfenuron on nonplant eukaryotes.
Heasley LR; Garcia G; McMurray MA
Eukaryot Cell; 2014 Nov; 13(11):1411-20. PubMed ID: 25217460
[TBL] [Abstract][Full Text] [Related]
5. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
[TBL] [Abstract][Full Text] [Related]
6. Forchlorfenuron alters mammalian septin assembly, organization, and dynamics.
Hu Q; Nelson WJ; Spiliotis ET
J Biol Chem; 2008 Oct; 283(43):29563-71. PubMed ID: 18713753
[TBL] [Abstract][Full Text] [Related]
7. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
Vardi-Oknin D; Golan M; Mabjeesh NJ
PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
[TBL] [Abstract][Full Text] [Related]
8. In silico docking of forchlorfenuron (FCF) to septins suggests that FCF interferes with GTP binding.
Angelis D; Karasmanis EP; Bai X; Spiliotis ET
PLoS One; 2014; 9(5):e96390. PubMed ID: 24787956
[TBL] [Abstract][Full Text] [Related]
9. Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines.
Kim KK; Singh RK; Khazan N; Kodza A; Singh NA; Jones A; Sivagnanalingam U; Towner M; Itamochi H; Turner R; Moore RG
Sci Rep; 2020 Feb; 10(1):3241. PubMed ID: 32094384
[TBL] [Abstract][Full Text] [Related]
10. Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.
Marcus EA; Tokhtaeva E; Turdikulova S; Capri J; Whitelegge JP; Scott DR; Sachs G; Berditchevski F; Vagin O
Biochem J; 2016 Jun; 473(12):1703-18. PubMed ID: 27048593
[TBL] [Abstract][Full Text] [Related]
11. Cellular requirements for the small molecule forchlorfenuron to stabilize the septin cytoskeleton.
DeMay BS; Meseroll RA; Occhipinti P; Gladfelter AS
Cytoskeleton (Hoboken); 2010 Jun; 67(6):383-99. PubMed ID: 20517926
[TBL] [Abstract][Full Text] [Related]
12. Reversible paralysis of Schistosoma mansoni by forchlorfenuron, a phenylurea cytokinin that affects septins.
Zeraik AE; Galkin VE; Rinaldi G; Garratt RC; Smout MJ; Loukas A; Mann VH; Araujo AP; DeMarco R; Brindley PJ
Int J Parasitol; 2014 Jul; 44(8):523-31. PubMed ID: 24768753
[TBL] [Abstract][Full Text] [Related]
13. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
Yamaji M; Ota A; Wahiduzzaman M; Karnan S; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Haniuda M
Cancer Med; 2017 Nov; 6(11):2646-2659. PubMed ID: 28960945
[TBL] [Abstract][Full Text] [Related]
14. Forchlorfenuron, a phenylurea cytokinin, disturbs septin organization in Saccharomyces cerevisiae.
Iwase M; Okada S; Oguchi T; Toh-e A
Genes Genet Syst; 2004 Aug; 79(4):199-206. PubMed ID: 15514439
[TBL] [Abstract][Full Text] [Related]
15. Small molecule perturbations of septins.
Heasley LR; McMurray MA
Methods Cell Biol; 2016; 136():311-9. PubMed ID: 27473917
[TBL] [Abstract][Full Text] [Related]
16. Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells.
Gultekin KE; Yurdakonar MK; Yaman E; Yuce US; Yilmaz A; Alp E; Celik A; Demiroz SM; Onen HI
Genet Mol Res; 2013 Nov; 12(4):5405-13. PubMed ID: 24301913
[TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.
Gerogianni I; Pitaraki E; Jagirdar RM; Kouliou O; Giannakou L; Giannopoulos S; Papazoglou E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Anticancer Res; 2019 Jul; 39(7):3809-3814. PubMed ID: 31262908
[TBL] [Abstract][Full Text] [Related]
18. ADP sensitizes ZL55 cells to the activity of cisplatin.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
[TBL] [Abstract][Full Text] [Related]
19. Abrogating G₂/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma.
Indovina P; Marcelli E; Di Marzo D; Casini N; Forte IM; Giorgi F; Alfano L; Pentimalli F; Giordano A
Cancer Biol Ther; 2014 Apr; 15(4):380-8. PubMed ID: 24365782
[TBL] [Abstract][Full Text] [Related]
20. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
